- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01233700
Brief Intervention to Prevent Poor Psychosocial Outcomes in Living Donors
February 10, 2022 updated by: Mary Amanda Dew, University of Pittsburgh
Brief Nursing Intervention to Prevent Poor Psychosocial Outcomes in Living Donors
The purpose of this study is to evaluate the potential effectiveness of a psychosocial intervention based on the principles of motivational interviewing.
The novel intervention will assist living donor candidates to think through any remaining concerns or questions that they may have about living donation.
If the intervention is effective, it may help to prevent post-donation problems related to psychological and health outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The protection of living donors' well-being and the prevention of any negative consequences of donation are among the foremost priorities in transplantation.
Some donors experience poor psychosocial outcomes after donation, including psychological distress, poor perceived physical well-being, and strained family relationships.
No preventive interventions have been mounted or tested for their ability to avert poor psychosocial outcomes in living donors.
The present study will provide an initial test of a new intervention for this purpose.
The new intervention utilizes motivational interviewing (MI) to address remaining concerns that individuals may have about proceeding with living donation.
Study participants will be randomly assigned to either (a) participate in the MI intervention (during which they will be asked to answer a series of questions to help them better delineate their reasons for and against proceeding with living organ donation), (b) participate in a comparison intervention designed to inform them about healthy lifestyle habits, or (c) not receive any intervention.
We plan to recruit a maximum of 150 adults who are considering whether to serve as living kidney or liver donors.
We hypothesize that participants receiving the MI intervention will have superior outcomes (less psychological distress, fewer physical health complaints, better interpersonal relationships within their family, better overall quality of life)after donation.
Study Type
Interventional
Enrollment (Actual)
113
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Score of 1 or greater on the Simmons Ambivalence Scale;
- Must be able to speak English;
- Have been evaluated as a potential living kidney or liver donor candidate;
- Aged 18 or older
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Motivational Interviewing
Subjects will receive two, individual telephone sessions with an interventionist, each lasting approximately 30-45 minutes.
The sessions will focus on assisting subjects to delineate their reasons for or against proceeding with living organ donation and assisting subjects to resolve any lingering concerns about their decisions regarding donation.
|
Standard motivational interviewing techniques will be applied to assist subjects to consider and work to resolve any remaining concerns, doubts, or ambivalence about their decision about donating an organ to someone else.
|
|
Active Comparator: Enhanced Standard Care
Subjects will receive two individual telephone sessions with an interventionist, each lasting approximately 30-45 minutes.
The sessions will focus on providing educational information to subjects regarding healthy lifestyle issues (healthy eating, diet, exercise, quitting smoking).
|
Educational information will be presented to subjects in didactic form on lifestyles issues of relevance to living donors.
|
|
No Intervention: Standard Care
Subjects will receive the standard care and education provided by the Living Donor Program at their medical center.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
psychological distress
Time Frame: 6 weeks post-donation
|
PRIME-MD depression and anxiety modules, Brief Symptom Inventory (BSI) anxiety items, Simmons Feelings About Donation items; Simmons Psychosocial Concerns About Donation items
|
6 weeks post-donation
|
|
somatic/physical health perceptions
Time Frame: 6 weeks post-donation
|
Concerns About Donation Effects items, Simmons Post-donation Medical Concerns, Brief Pain Inventory short form, FACIT-fatigue scale, Post-surgery Body Image Questionnaire, Post-donation Symptom Checklist, Simmons Concerns About Future Health items, Simmons Perceived Stressfulness of Donation items
|
6 weeks post-donation
|
|
interpersonal relationship quality and distress
Time Frame: 6 weeks post-donation
|
Simmons Family Relationship items, Short Dyadic Adjustment Scale, Family ICPS conflict and intimacy subscales
|
6 weeks post-donation
|
|
quality of life
Time Frame: 6 weeks post-donation
|
RAND-12
|
6 weeks post-donation
|
|
psychological distress
Time Frame: 3 months post-donation
|
PRIME-MD depression and anxiety modules, BSI anxiety items, Simmons Feelings About Donation items; Simmons Psychosocial Concerns About Donation items
|
3 months post-donation
|
|
somatic/physical health perceptions
Time Frame: 3 months post-donation
|
Concerns About Donation Effects items, Simmons Post-donation Medical Concerns, Brief Pain Inventory short form, FACIT-fatigue scale, Post-surgery Body Image Questionnaire, Post-donation Symptom Checklist, Simmons Concerns About Future Health items, Simmons Perceived Stressfulness of Donation items
|
3 months post-donation
|
|
interpersonal relationship quality and distress
Time Frame: 3 months post-donation
|
Simmons Family Relationship items, Short Dyadic Adjustment Scale, Family ICPS conflict and intimacy subscales
|
3 months post-donation
|
|
quality of life
Time Frame: 3 months post-donation
|
RAND-12
|
3 months post-donation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction with intervention
Time Frame: pre-donation (on average, 1 week post-intervention but before donation has occurred)
|
adapted Client Satisfaction Scale
|
pre-donation (on average, 1 week post-intervention but before donation has occurred)
|
|
Quality of decision to donate
Time Frame: pre-donation (on average, 1 week post-intervention but before donation has occurred)
|
Simmons Ambivalence Scale items; Decision Conflict Scale, Decision Satisfaction Scale items
|
pre-donation (on average, 1 week post-intervention but before donation has occurred)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Mary Amanda Dew, Ph.D., University of Pittsburgh
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (Actual)
April 1, 2013
Study Completion (Actual)
April 1, 2013
Study Registration Dates
First Submitted
October 26, 2010
First Submitted That Met QC Criteria
November 2, 2010
First Posted (Estimate)
November 3, 2010
Study Record Updates
Last Update Posted (Actual)
March 2, 2022
Last Update Submitted That Met QC Criteria
February 10, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- R21NR011149 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Living Donation
-
London Health Sciences Centre Research Institute...Canadian Institutes of Health Research (CIHR)CompletedFractures | Living Kidney Donor | Fragility Fractures | Nephrectomy,Kidney Donation | Living Kidney Donation
-
University of ChicagoCompleted
-
Helsinki University Central HospitalUniversity of OuluUnknownLiving Kidney Donation
-
University of California, IrvineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHealthy | Living Kidney DonationUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownPatients Awaiting a Living Kidney DonationFrance
-
London Health Sciences Centre Research Institute...CompletedCardiovascular Disease | Mortality | Living Kidney Donors | Living Kidney Donor | Living Donor Nephrectomy | Living Kidney Donation | Major Adverse Cardiovascular Events (MACE)
-
Lawson Health Research InstituteNovartis; Canadian Institutes of Health Research (CIHR); Astellas Pharma Canada...Completed
-
Mayo ClinicRecruitingHypertension | Nephrectomy | Living Kidney DonationUnited States
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
London Health Sciences Centre Research Institute...University of CalgaryCompletedLaparoscopic Nephrectomy | Hydrocele | Living Kidney Donor | Hydrocelectomy | Hydrocele of Tunica Vaginalis | Living Kidney Donation
Clinical Trials on Motivational Interviewing
-
University of Maryland, BaltimoreMaryland Department of Health and Mental HygieneCompletedFractures, Bone | Smoking, TobaccoUnited States
-
Johns Hopkins UniversityZanvyl and Isabelle Krieger FundCompleted
-
Massachusetts General HospitalCompletedACS - Acute Coronary SyndromeUnited States
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Completed
-
Qazvin University Of Medical SciencesCompletedObesity, AdolescentIran, Islamic Republic of
-
Veterans Medical Research FoundationThe Tug McGraw FoundationCompleted
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); University of Iowa; American... and other collaboratorsCompletedChildhood ObesityUnited States
-
University of StellenboschUniversity of British Columbia; McMaster UniversityCompletedText Messaging Plus Motivational Interviewing in Promotion of Breastfeeding Among HIV-infected WomenHIV Infections | Breast FeedingSouth Africa
-
Department of Public Health Medicine, MARA University...Not yet recruiting
-
Istituto Auxologico ItalianoNot yet recruitingSleep Apnea, Obstructive | Motivational InterviewingItaly